CVE-2026-9844

Name: CVE-2026-9844
Creator: NVD / NIST
Published: 2026-06-02T14:17:14.93+00:00
License: https://creativecommons.org/publicdomain/zero/1.0/

HIGHCVSS 8.8/10EPSS 0.24%

Last modified Jun 17, 2026

CVE-2026-9844 is a high-severity vulnerability rated 8.8/10 on the CVSS scale. Use of default credentials vulnerability in Roche Diagnostics navify Digital Pathology (RabbitMQ Management interface modules) allows Default Usernames and Passwords. This issue affects navify Digital Pathology: from 2.0.0 before 2.4.1.. EPSS estimates a 0.24% chance of exploitation in the next 30 days.

Description

Use of default credentials vulnerability in Roche Diagnostics navify Digital Pathology (RabbitMQ Management interface modules) allows Default Usernames and Passwords. This issue affects navify Digital Pathology: from 2.0.0 before 2.4.1.

Metrics

CVSS 4.0

8.8/10

CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:L/VI:H/VA:H/SC:L/SI:L/SA:L/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:N/AU:Y/R:U/V:D/RE:M/U:Green

EPSS Probability

0.24%

14.9th percentile

Probability of exploitation in the next 30 days. Learn more

Weakness Enumeration

CWE-1392

References

https://diagnostics.roche.com/global/en/legal/product-security-advisory.html

Timeline

Published: Jun 2, 2026
Last Modified: Jun 17, 2026
Status: Deferred

Frequently Asked Questions

What is CVE-2026-9844?

How severe is CVE-2026-9844?

CVE-2026-9844 has a CVSS score of 8.8/10 (HIGH severity). The EPSS model estimates a 0.24% probability of exploitation in the next 30 days.

How do I fix CVE-2026-9844?

Check the vendor references and advisories linked above for patched versions and mitigation guidance. You can also run a Strix scan to test if your systems are affected.

Are you affected by CVE-2026-9844?

Run a free Strix scan to check your systems for this vulnerability.

Scan your code now

Source: NVD / NIST